Lantheus Holdings, Inc. ( LNTH) - Stock Earnings
LNTH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
LNTH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 54.1 million USD | 406.8 million USD |
| 2026Q1 | 118.4 million USD | 377.3 million USD |
| 2026Q2 | 75.0 million USD | 388.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LNTH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 326.7 million USD | 1.3 billion USD |
| 2024 | 312.4 million USD | 1.5 billion USD |
| 2025 | 233.6 million USD | 1.5 billion USD |
| 2026 Est. | — | — |
LNTH
Price: $100.02
Earnings Per Share: 4.18 USD
P/E Ratio: 24.16
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 24390
Ebitda: 17.5 millionMarket Capitalization: 6.5 billion